FIPB to clear pharma FDI till Act is changed
|
BS REPORTER
New
Delhi, 3 December
Foreign
investment proposals in pharma companies will go to the Foreign Investment
Promotion Board ( FIPB) for approval till the Competition Commission of India
Act is amended.
This
means that the status quo has been maintained for brownfield pharma projects.
“Every proposal for foreign investment in existing Indian pharmaceutical
companies will go to FIPB till the time the Competition Act is amended,” a
source said.
The
decision was taken at a meeting called by Prime Minister Manmohan Singh today
to formalise norms for pharma foreign direct investment ( FDI) policy,
according to sources. Finance Minister P Chidambaram, Commerce and Industry
Minister Anand Sharma and Health Minister Ghulam Nabi Azad, among others,
were present at the high- level meeting, they said.
Today’s
meeting was called to decide on two important issues in the pharma FDI policy
- the limit to which foreign companies will be allowed to acquire shares in a
domestic company and the role of Competition Commission of India ( CCI) in
mergers and acquisitions.
While
the finance ministry wants only those cases involving FDI beyond 49 per cent
in units to be considered by FIPB, commerce ministry favours all foreign
investments in pharma units to be approved by FIPB.
The
issue was taken up by the government after the acquisition of big Indian
companies — including Ranbaxy, Shanta Biotech and Piramal Health Care’s
health unit - by foreign companies. The domestic industry is apprehensive
that the entry of foreign players in the Indian market may impact the
availability of generic medicines as the overseas companies would focus on
costly patented medicines.
|
Coming soon: Get refund on travel expenses while repairing
your car
|
SOMASROY CHAKRABORTY
Kolkata,
3 December
Soon
you can claim reimbursement from your insurer on your travel- related
expenses if your car is getting repaired.
Bharti
AXA General Insurance, the joint venture between Indias Bharti Enterprises
and Frances AXA, plans to introduce a new product that promises to reimburse
the policyholders travel expenses when the car is in repair shop.
The
product is likely to be named Garage Cash and the insurance company has
already sought the regulators approval.
“I
dont think a similar product is currently offered by any insurance company.
It is different from the traditional motor insurance that takes care of the
repairing expenses. This product will allow customers to claim the money they
spend on travel while their car is in a garage,” Manish Kishore Mishra, zonal
vice president – east at Bharti AXA General Insurance, told Business
Standard. He added the company was yet to work out the pricing of the
product. "Those details will be chalked out once we get the necessary
approvals," said Mishra.
The
company is currently awaiting regulatory approval for about eight insurance
products including cover for involuntary unemployment.
A
policyholder can claim reimbursement for his monthly expenses such as house
rent, loan installments, credit card bills, and childrens school fees if he
loses his job. The insurance company will reimburse these expenses for a
specific period, for three or six months.
“It
does not mean that we are encouraging people to lose their job,"
Amarnath Ananthanarayanan, CEO and managing director of Bharti AXA General
Insurance, said with a smile.
"The
idea is to allow the individual focus on his search for a new job without
worrying about monthly expenses," he added.
Bharti
AXA General Insurance currently has 58 products catering to the needs of
urban, semi- urban and rural population. The company has sold over 2 million
policies and settled more than 3 million claims since its inception in August
2008.
So
far in 2012, motor insurance has the largest ( 68 per cent) share in its
total business, followed by health and personal accident ( 21 per cent) and
commercial lines ( 11 per cent).
In
terms of geography, the western region accounts for most of its business with
35 per cent share. The company has tie- ups for cash settlements with over
3,800 hospitals and 2,000 car garages across India.
CASH
FROM CAR
|The
product is likely to be named Garage Cash |Bharti AXA General Insurance has
already sought the regulators approval to launch the product
|The
pricing of the product is yet to be worked out |The company is currently
awaiting regulatory approval for about eight insurance products, including cover
for involuntary unemployment
A
Ananthanarayanan, CEO and managing director of Bharti AXA General Insurance
|
|
No comments:
Post a Comment